NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/12/2024
Back to search
Official data from USPTO
EVEREST CLINICAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
09/12/2024
Trademark type
Combined
Nice classes
42
Filing date
06/25/2018
Registration date
02/26/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/12/2024
Last transaction
09/12/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
10/21/2003
First use in commerce
10/21/2003
Drawing code
3
Owner type
03
Owner location
Ontario, CA
Examiner
DELGIZZI, RONALD
Current location
Historical data usage
Mark description
The mark consists of the word "EVEREST" represented in stylized font primarily in blue letters with the first letter "E" appears in light blues shades and is larger in size than the following letters, and wherein the first letter "E is superimposed across a design consisting of two overlapping triangles, also varying in color between light and dark shades of blue. Additionally, the wording "CLINICAL RESEARCH" is located underneath "EVEREST" and the design and appears in smaller size font in the color black.
Holders and representatives
Holders
E. C. (pessoa física)
Representatives
Camille M. Miller COZEN O'CONNOR
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Biomedicalpharmaceuticalbiotechnology and health-related research study servicesconducting clinical trials in the field of clinical trials of drugsmedical devices and other interventions to determine efficacy and safetyparticularlyproviding the selection of trial subjects in accordance with research design criteriatrial management and site monitoringmonitoring trial participants for adverse reactions and preparation and presentation of reports of adverse reactionsadministration of clinical trial data and safety monitoring boardscollection and management of study dataclinical data management services and medical codinganalysis of study data including selection and application of statistical tests to study dataproviding biostatistics and statistical programmingdispensing drugs and managing drug inventoriesmonitoring design and conduct of trials for compliance with applicable regulations and policies and preparation and presentation of compliance reportsdevelopment and maintenance of Internet websites for reporting on studiesmedical writing and graphic design of research study protocolspreparation of reports of research studies and abstracts of reportspreparation and presentation of reports to study sponsors and regulatory authorities
Publications
History of USPTO decisions and trademark events.
22 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/12/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/12/2024
E815
TEAS SECTION 8 & 15 RECEIVED
03/01/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/26/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/26/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/11/2018
PUBO
PUBLISHED FOR OPPOSITION
12/11/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/21/2018
ALIE
ASSIGNED TO LIE
11/02/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/19/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/18/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/18/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/18/2018
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
10/16/2018
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
10/16/2018
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
10/16/2018
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
10/16/2018
DOCK
ASSIGNED TO EXAMINER
10/15/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/03/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/30/2018
NWAP
NEW APPLICATION ENTERED
06/28/2018
Continuous trademark protection
Get notified about every new filing that threatens EVEREST CLINICAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.